Clinical Trial Update: Cholinergic Urticaria - Efficacy of Dupilumab [Phase 2]

View source ↗

Summary

Phase 2 trial assessing dupilumab for cholinergic urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholinergic Urticaria

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Cholinergic Urticaria | Phase 2 | Status: COMPLETED